Home Two Innovative Medical Devices Approved by China's NMPA

Two Innovative Medical Devices Approved by China's NMPA

Jul 04, 2026 07:55 CST Updated 07:55
Singular Medical

Developer, Manufacturer, and Seller of Cardiac Rhythm Management Products

Skynor Medical

Vascular Minimally Invasive Intervention Product Developer

Image
Image

Source: National Medical Products Administration


Recently, the National Medical Products Administration approved the registration applications for the implantable cardiac event monitor from Suzhou Singular Medical Equipment Co., Ltd. and the intracranial stent from Skynor Medical (Shanghai) Co., Ltd.


图片


Implantable Cardiac Event Monitor


This product consists of an Implantable Cardiac Monitor (ICM) and a patient activator. It is designed to record subcutaneous electrocardiograms and is indicated for patients who exhibit clinical symptoms or have experienced transient symptoms, are at increased risk of arrhythmia, or have been diagnosed with arrhythmia.
This product is the first domestically developed implantable cardiac monitor (ICM) in China, filling the gap in the ICM field in our country.


图片


Intracranial Stent


This product consists of a stent and a delivery system, designed to be used in conjunction with embolization devices for the treatment of wide-necked saccular aneurysms in the anterior circulation of the intracranial arteries. The stent features a closed-cell helical wire interlocking design, a closed-loop structure, and full radiopacity, intended to provide excellent flexibility and wall apposition, allow for recapture and repositioning, and ensure accurate placement.



This article is reposted for sharing purposes only. The views expressed herein represent solely those of the original author and platform, and do not reflect the views of this platform. In the event that any content in this article overlaps with original content published on your platform, or has been used without authorization, such actions are attributable to the original platform, as this platform merely reposts the material. You may contact us immediately to request removal of the article, and we will respond promptly.

I love every like and view from you!
Image